Ghadjar Pirus, Rubie Claudia, Aebersold Daniel M, Keilholz Ulrich
Department of Radiation Oncology, Inselspital, Bern University Hospital, University of Bern, Freiburgstrasse, Bern, Switzerland.
Int J Cancer. 2009 Aug 15;125(4):741-5. doi: 10.1002/ijc.24468.
Chemokines are a superfamily of small chemotactic cytokines, which interact with their G-protein-coupled receptors. These interactions regulate multiple physiological functions, particularly tissue architecture and compartment-specific migration of white blood cells. It has been found that the chemokine/chemokine receptor system has been utilized by cancer cells for migration and metastasis. The chemokine receptor CCR6 is expressed in colorectal cancer and several other cancer types, and stimulation by its physiological chemokine ligand CCL20 has been reported to promote cancer cell proliferation and migration in vitro. Moreover, CCR6/CCL20 interactions apparently play a role in organ selective liver metastasis of colorectal cancer. Here, we review the literature on expression patterns of CCL20 and CCR6 and their physiological interactions as well as the currently presumed role of CCR6 and CCL20 in the formation of colorectal cancer liver metastasis, providing a potential basis for novel treatment strategies.
趋化因子是一类小的趋化细胞因子超家族,它们与G蛋白偶联受体相互作用。这些相互作用调节多种生理功能,特别是组织结构和白细胞的特定区域迁移。现已发现,癌细胞利用趋化因子/趋化因子受体系统进行迁移和转移。趋化因子受体CCR6在结直肠癌和其他几种癌症类型中表达,据报道,其生理性趋化因子配体CCL20的刺激可促进体外癌细胞的增殖和迁移。此外,CCR6/CCL20相互作用显然在结直肠癌的器官选择性肝转移中起作用。在此,我们综述了关于CCL20和CCR6的表达模式及其生理相互作用的文献,以及目前推测的CCR6和CCL20在结直肠癌肝转移形成中的作用,为新的治疗策略提供潜在依据。